| 2024-03-11 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 3,517 0.0063% | $193.73 | $681,348 | -13.85% | |
| 2022-08-11 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 800 0.0015% | $255.20 | $204,160 | -29.78% | |
| 2021-08-30 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 4,001 0.0073% | $282.13 | $1.13M | -29.41% | |
| 2021-06-10 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 6,802 0.0123% | $189.19 | $1.29M | +7.44% | |
| 2021-05-14 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 710 0.0013% | $172.29 | $122,326 | +18.76% | |
| 2021-03-10 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 8,000 0.0147% | $190.44 | $1.52M | +12.47% | |
| 2021-03-04 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 2,075 0.004% | $192.00 | $398,396 | +15.71% | |
| 2020-12-16 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 435 0.0008% | $186.18 | $80,988 | +17.65% | |
| 2020-08-06 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 5,000 0.0095% | $153.79 | $768,950 | +23.86% | |
| 2020-05-15 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 435 0.0008% | $140.69 | $61,200 | +27.53% | |
| 2020-05-13 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 8,000 0.0152% | $127.80 | $1.02M | +39.62% | |
| 2020-03-04 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 2,555 0.0047% | $90.76 | $231,888 | +57.14% | |
| 2020-03-03 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 450 0.0009% | $88.35 | $39,758 | +70.71% | |
| 2020-02-26 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 195 0.0004% | $86.60 | $16,887 | +72.94% | |
| 2019-03-05 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 2,240 0.0051% | $58.53 | $131,107 | +44.37% | |
| 2019-02-28 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 185 0.0004% | $59.16 | $10,945 | +39.6% | |
| 2018-12-18 | Sale | Repligen Corporation RGEN | Senior VP, R&D | 622 0.0014% | $54.44 | $33,862 | +40.52% |